Beta-glucan, Product Claims and Satiety

March 5, 2024 updated by: General Mills

Effects of Beta-glucan and Product Claims for Breakfast Bars on Appetite Response and Consumer Preference: a Randomized Controlled Trial

This is a digital clinical trial to investigate satiety and consumer preference in responses to three test breakfast bars with varying level of dietary fiber, beta-glucan, and product packages (with or without product claims) in healthy adults.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
130

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Minneapolis, Minnesota, United States, 55427
        • No physical visit to a research facility is required.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adults 18-70 years.
  • Habitual snack bar consumers (consume bars at least 3 times a week).
  • Body mass index 20-29.9 kg/m² (based on self-reported weight and height).
  • Understand the study procedures.
  • Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
  • Willing to follow study procedures on test days.
  • Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day.
  • Willing to provide informed consent to participate in the study.
  • Willing to maintain confidentiality of the study and test products.

Exclusion Criteria:

  • Pregnant or lactating women, or women who are planning to become pregnant during the study
  • Known food allergies, sensitivity, or intolerance to any food or food ingredients
  • Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification
  • Taking medications that affect appetite, metabolism, or blood pressure
  • Taking supplements with dietary fiber
  • Presence of acute diseases or infection
  • Presence or history of chronic diseases
  • Diagnosed with eating disorders
  • Restraint eaters
  • Lost or gained 5 pounds or more in the past 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Placebo Comparator: Control breakfast bar with low dietary fiber without product claims
Other: Foods with beta-glucan from oats and barley
Breakfast bars made with varying levels of total dietary fiber and beta-glucan, with or without claims on package image
Other Names:
  • Food
Experimental: Test breakfast bar with high dietary fiber without product claims
Other: Foods with beta-glucan from oats and barley
Breakfast bars made with varying levels of total dietary fiber and beta-glucan, with or without claims on package image
Other Names:
  • Food
Experimental: Test breakfast bar with high dietary fiber with product claims
Other: Foods with beta-glucan from oats and barley
Breakfast bars made with varying levels of total dietary fiber and beta-glucan, with or without claims on package image
Other Names:
  • Food

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Hunger
Time Frame: 30 minutes after consumption
Hunger as measured by visual analog scales in mm using appetite questionnaires
30 minutes after consumption
Hunger
Time Frame: 60 minutes after consumption
Hunger as measured by visual analog scales in mm using appetite questionnaires
60 minutes after consumption
Hunger
Time Frame: 90 minutes after consumption
Hunger as measured by visual analog scales in mm using appetite questionnaires
90 minutes after consumption
Hunger
Time Frame: 120 minutes after consumption
Hunger as measured by visual analog scales in mm using appetite questionnaires
120 minutes after consumption
Hunger
Time Frame: 180 minutes after consumption
Hunger as measured by visual analog scales in mm using appetite questionnaires
180 minutes after consumption
Fullness
Time Frame: 30 minutes after consumption
Fullness as measured by visual analog scales in mm using appetite questionnaires
30 minutes after consumption
Fullness
Time Frame: 60 minutes after consumption
Fullness as measured by visual analog scales in mm using appetite questionnaires
60 minutes after consumption
Fullness
Time Frame: 90 minutes after consumption
Fullness as measured by visual analog scales in mm using appetite questionnaires
90 minutes after consumption
Fullness
Time Frame: 120 minutes after consumption
Fullness as measured by visual analog scales in mm using appetite questionnaires
120 minutes after consumption
Fullness
Time Frame: 180 minutes after consumption
Fullness as measured by visual analog scales in mm using appetite questionnaires
180 minutes after consumption
Desire to eat
Time Frame: 30 minutes after test meal consumption
Desire to eat as measured by visual analog scales in mm using appetite questionnaires
30 minutes after test meal consumption
Desire to eat
Time Frame: 60 minutes after test meal consumption
Desire to eat as measured by visual analog scales in mm using appetite questionnaires
60 minutes after test meal consumption
Desire to eat
Time Frame: 90 minutes after test meal consumption
Desire to eat as measured by visual analog scales in mm using appetite questionnaires
90 minutes after test meal consumption
Desire to eat
Time Frame: 120 minutes after test meal consumption
Desire to eat as measured by visual analog scales in mm using appetite questionnaires
120 minutes after test meal consumption
Desire to eat
Time Frame: 180 minutes after test meal consumption
Desire to eat as measured by visual analog scales in mm using appetite questionnaires
180 minutes after test meal consumption
Prospective consumption
Time Frame: 30 minutes after test meal consumption
Prospective consumption as measured by visual analog scales in mm using appetite questionnaires
30 minutes after test meal consumption
Prospective consumption
Time Frame: 60 minutes after test meal consumption
Prospective consumption as measured by visual analog scales in mm using appetite questionnaires
60 minutes after test meal consumption
Prospective consumption
Time Frame: 90 minutes after test meal consumption
Prospective consumption as measured by visual analog scales in mm using appetite questionnaires
90 minutes after test meal consumption
Prospective consumption
Time Frame: 120 minutes after test meal consumption
Prospective consumption as measured by visual analog scales in mm using appetite questionnaires
120 minutes after test meal consumption
Prospective consumption
Time Frame: 180 minutes after test meal consumption
Prospective consumption as measured by visual analog scales in mm using appetite questionnaires
180 minutes after test meal consumption

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Flavor rating
Time Frame: 30 minutes after test meal consumption
Subjective ratings on liking of the product flavor using Likert scales
30 minutes after test meal consumption
Sweetness rating
Time Frame: 30 minutes after test meal consumption
Subjective ratings on sweetness of the product using Likert scales
30 minutes after test meal consumption
Texture rating
Time Frame: 30 minutes after test meal consumption
Subjective ratings on liking of the product texture using Likert scales
30 minutes after test meal consumption
Overall product liking
Time Frame: 30 minutes after test meal consumption
Subjective ratings on overall liking of the product using Likert scales
30 minutes after test meal consumption
Purchase intent
Time Frame: 180 minutes after test meal consumption
Likelihood of buying the product using Likert scales
180 minutes after test meal consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
General Mills

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 28, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 28, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 27, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 3, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 5, 2021

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 6, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 5, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2021/01/7

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Foods with beta-glucan from oats and barley

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings